INFORMING THE PATIENT ABOUT OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN KAZAKHSTAN
Introduction: The implantable cardioverter defibrillator (ICD) has been implemented in most countries for the treatment of patients at high risk of sudden death from arrhythmia, and has been proven to be effective. To provide high quality care it was identified that system have to patient-oriented. Thus the satisfaction of ICD patients with information about cardioverter-defibrillator implantation one of the crucial issue.
The aim is to study the satisfaction of ICD patients with information about technology cardioverter-defibrillator implantation.
Materials and methods: The online survey was conducted by phone. The oral consent to participate in the survey was obtained. The survey provided in Russian or Kazakh languages, depending patient preferences. The survey was conducted in the period 2020, among patients who received an ICD in the period from 2017 to 2020 in Almaty city and Kyzylorda region. Statistical processing was carried out using the SPSS 13 software. The Local Ethics Committee of Kazakhstan’s Medical University «KSPH» (Almaty, Kazakhstan) approved the study.
Results: The high number of Almaty city respondents in comparison of the Kyzylorda region unsatisfactory with the level of the providing information on the effect of ICD (P <0.009), the impact of ICD on driving a car, traveling, playing sports or other activities, what shock means and when they occur, and how daily life might change (P <0.046). Only respondents from Almaty city assessed neutral or unsatisfactory (P <0.004) on informing how to care for a wound after implantation and to manage pain, symptoms and medication when returning home (P <0.002).
Conclusion: There are needs to improve in providing information on effects of ICD technology in Almaty city higher in comparison with Kyzylorda region.
Temirkhan S. Begisbayev 1, https://orcid.org/0000-0001-7536-3947
Marzhan D. Brimzhanova1, https://orcid.org/0000-0003-3517-4687
Nazgul S. Akhtaeva2, https://orcid.org/0000-0002-0835-9814
Lyazzat K. Kosherbayeva2, https://orcid.org/0000-0001-8376-4345
Shattyk E. Toleugali2, https://orcid.org/0000-0001-6496-6849
1 Kazakhstans Medical University "Higher School of Public Health", Almaty, Republic of Kazakhstan;
2 Asfendiyarov Kazakh National Medical University, Almaty, Republic of Kazakhstan.
1. Камалиев М.А., Альмуханова А.Б., Бапаева М., Перемитина А.Д. Медицинская эффективность после имплантации кардиовертер-дефибриллятора // Вестник КазНМУ. 2018. №03-2018 С.283-284
2. Anantha Narayanan M., Vakil K., Reddy Y.N., Baskaran J., Deshmukh A., Benditt D.G., Adabag S. Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials // JACC Clin Electrophysiol. 2017 Sep.3(9):962-970. doi: 10.1016/j.jacep.2017.02.006. Epub 2017 May 31. PMID: 29759721.
3. Bazoukis G., Tse G., Korantzopoulos P., Liu T., Letsas K.P., Stavrakis S., Naka K.K. Impact of Implantable Cardioverter-Defibrillator Interventions on All-Cause Mortality in Heart Failure Patients: A Meta-Analysis // Cardiol Rev. 2019 May/Jun. 27(3):160-166. doi: 10.1097/CRD.0000000000000226. PMID: 30052536.
4. Chute C.G. Coding patient information, reimbursement for care, and the ICD transition. Virtual Mentor. 2013 Jul 1. 15(7):596-9. doi: 10.1001/virtualmentor.2013.15.7.stas1-1307. PMID: 23890432.
5. Constand M.K., MacDermid J.C., et al. Scoping review of patient-centered care approaches in healthcare // BMC Health Serv Res. 2014. 14:271. Published 2014 Jun 19. doi:10.1186/1472-6963-14-271
6. Goldenberg I., Huang D.T., Nielsen J.C. The role of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome // Eur Heart J. 2020 Jun 1. 41(21):2003-2011. doi: 10.1093/eurheartj/ehz788. PMID: 31713598.
7. Higuera L., Holbrook R., Wherry K., et al. Comparison of cost-effectiveness of implantable cardioverter defibrillator therapy in patients for primary prevention in Latin America: an analysis using the Improve SCA study // J Med Econ. 2021 Jan-Dec. 24(1):173-180. doi: 10.1080/13696998.2021.1877451. PMID: 33471579.
8. Hill L.M., McIlfatrick S., Taylor B., Dixon L., Fitzsimons D. Implantable cardioverter defibrillator (ICD) functionality: patient and family information for advanced decision-making // BMJ Support Palliat Care. 2019 Nov 26:bmjspcare-2019-001835. doi: 10.1136/bmjspcare-2019-001835. Epub ahead of print. PMID: 31771959.
9. Cardiovascular diseases (CVDs) / Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (Accessed 28 August 2021).
10. Johnson A.E., Bell Y.K., Hamm M.E., Saba S.F., Myaskovsky L. A Qualitative Analysis of Patient-Related Factors Associated With Implantable Cardioverter Defibrillator Acceptance // Cardiol Ther. 2020 Dec. 9(2):421-432. doi: 10.1007/s40119-020-00180-9. Epub 2020 May 31. PMID: 32476091; PMCID: PMC7584700.
11. Kedia R., Saeed M. Implantable cardioverter-defibrillators: indications and unresolved issues // Tex Heart Inst J. 2012. 39(3):335-341.
12. Kitson A., Marshall A., Bassett K., Zeitz K. What are the core elements of patient-centred care? A narrative review and synthesis of the literature from health policy, medicine and nursing // J Adv Nurs. 2013 Jan. 69(1):4-15. doi: 10.1111/j.1365-2648.2012.06064.x. Epub 2012 Jun 19. PMID: 22709336.
13. Konstantino Y., Shafat T., et al. Incidence of Implantable Cardioverter Defibrillator Therapy and Mortality in Primary and Secondary Prevention of Sudden Cardiac Death // Isr Med Assoc J. 2015 Dec. 17(12):760-3. PMID: 26897978.
14. Lui M, Safiri S, Mereke A, et al. Burden of Ischemic Heart Disease in Central Asian Countries, 1990-2017 // Int J Cardiol Heart Vasc. 2021. 33:100726. Published 2021 Feb 7. doi:10.1016/j.ijcha.2021.100726
15. Bapayeva M.K., Almukhanova A.B., Kamaliyev M.A., et al. Organization of Interventional Arrhythmological Care in The Republic Of Kazakhstan Sys Rev Pharm // A multifaceted review journal in the field of pharmacy. 2020. 11(4): 419-421. E-ISSN 0976-2779 P-ISSN 0975-8453
16. Masri Ahmad et al. Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Systematic Review and Meta-Analysis // JACC. Clinical electrophysiology vol. 2019. 5,2: 152-161. doi:10.1016/j.jacep.2018.11.011
17. Mead N., Bower P. Patient-centredness: a conceptual framework and review of the empirical literature // Soc Sci Med. 2000. 14:1087–1110. doi: 10.1016/S0277-9536(00)00098-8.
18. Mealing S., Woods B., Hawkins N., et al. Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure // Heart. 2016 Nov 1. 102(21):1742-1749. doi: 10.1136/heartjnl-2015-308883. Epub 2016 Jul 13. PMID: 27411837; PMCID: PMC5099208.
19. Mirowski M., Reid P.R., et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings // N Engl J Med 1980;303(6):322–4
20. Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K. et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2016 update: a report from the American Heart Association // Circulation. 2016. 133:e38–e360. doi: 10.1161/CIR.0000000000000350.
21. Pedersen S.S., Knudsen C., et al. Living with an implantable cardioverter defibrillator: patients' preferences and needs for information provision and care options // Europace. 2017 Jun 1;19(6):983-990. doi: 10.1093/europace/euw109. PMID: 27267553
22. Pekka-Raatikainen M.J., Arnar D.O., et al. A Decade of Information on the Use ofCardiac Implantable Electronic Devices andInterventional Electrophysiological Proceduresin the European Society of Cardiology Countries: 2017. Report fromthe EuropeanHeart RhythmAssociation // Europace. 2017. Vol. 19. Р.81-90.
23. Pick J.M., Batra A.S. Implantable cardioverter-defibrillator implantation for primary and secondary prevention: indications and outcomes. Cardiol Young. 2017 Jan. 27(S1):S126-S131. doi: 10.1017/S1047951116002365. PMID: 28084973.
24. Roth G.A., Abate D., Abate K.H., et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 // Lancet. 2018. 392:1736-1788
25. Shun-Shin M.J., Zheng S.L., et al. Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials // Eur Heart J. 2017 Jun 7. 38(22):1738-1746. doi: 10.1093/eurheartj/ehx028. PMID: 28329280; PMCID: PMC5461475. https://pubmed.ncbi.nlm.nih.gov/28329280/
26. Strachan P.H., de Laat S., Carroll S.L., et al. Readability and content of patient education material related to implantable cardioverter defibrillators // J Cardiovasc Nurs. 2012. 27(6):495-504. doi:10.1097/JCN.0b013e31822ad3dd
27. Townsend N., Kazakiewicz D., Lucy Wright F. et al. Epidemiology of cardiovascular disease in Europe // Nat Rev Cardiol. 2021. https://doi.org/10.1038/s41569-021-00607-3
28. Vehmeijer J.T., Brouwer T.F., et al. Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis // Eur Heart J. 2016 May 7. 37(18):1439-48. doi: 10.1093/eurheartj/ehv735. Epub 2016 Feb 11. PMID: 26873095; PMCID: PMC4914887. https://pubmed.ncbi.nlm.nih.gov/26873095/
29. Woodward M. Cardiovascular Disease and the Female Disadvantage // Int J Environ Res Public Health. 2019. 16(7):1165. Published 2019 Apr 1. doi:10.3390/ijerph16071165
References: [1]
1. Kamaliev M.A., Al'muhanova A.B., Bapaeva M., Peremitina A.D. Meditsinskaya effektivnost' posle implantatsii kardioverter-defibrillyatora [Medical efficacy after implantation of a cardioverter defibrillator]. Vestnik KazNMU [Bulletin of KazNMU]. 2018. №03-2018 С 283-284
Количество просмотров: 366
Категория статей:
Оригинальные исследования
Библиографическая ссылка
Begisbayev T.S., Brimzhanova M.D., Akhtaeva N.S., Kosherbayeva L.K., Toleugali Sh.E. Informing the patient about of implantable cardioverter defibrillators in Kazakhstan // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 1, pp. 64-70. doi 10.34689/SH.2022.21.1.008Похожие публикации:
МЕХАНИКАЛЫҚ САРҒАЮ ОПЕРАЦИЯСЫ КЕЗІНДЕ КОАГУЛОПАТИЯЛЫҚ ҚАН КЕТУДІҢ АЛДЫН АЛУ ӘДІСІ
ОПТИМИЗАЦИЯ РЕЗУЛЬТАТОВ АУТОДЕРМОПЛАСТИКИ ПРИ ЛЕЧЕНИИ ГРАНУЛИРУЮЩИХ ГНОЙНЫХ РАН
BASICS OF REHABILITATION OF CHILDREN AFTER OPERATIONS ON THE COLON AND ANORECTAL AREA
HEALTH INDICATORS OF FIRST-YEAR-OF-LIFE CHILDREN IN THE REPUBLIC OF KAZAKHSTAN FOR 2013-2022
ОЦЕНКА УДОВЛЕТВОРЕННОСТИ ТРУДОВОЙ ДЕЯТЕЛЬНОСТЬЮ ВРАЧЕЙ АНЕСТЕЗИОЛОГОВ-РЕАНИМАТОЛОГОВ ГОРОДА АСТАНА